The Consulate General of Canada in Boston is accepting applications for the 2019 Oncology Partnering Initiative, looking for Canadian companies that are developing innovative therapeutics, diagnostics, or research tools addressing needs of companies, researchers or healthcare systems in the oncology space
Cyclica announced the launch of MatchMaker™, a novel deep learning engine which combines molecular biophysics and deep learning to predict binding of new drug molecules to all proteins with high accuracy and high throughput, moving beyond the reliance on molecular docking.
Mobio Interactive's first scientific paper, an active randomised controlled trial, demonstrated that their mindfulness meditation app may provide immediate effects on mood and stress while also providing long-term benefits for attentional control compared to placebo.
Supported by Ontario Genomics, the Genomic Applications Partnership Program (GAPP) funds downstream research and development projects that address real world opportunities and challenges defined by “Receptor” organizations such as industry, government, or not-for-profit entities.
Presented by the Impact Centre, Entrepreneurship 100 is an event series aimed at connecting curious people with diverse entrepreneurs, featuring an interactive Q&A conversation and a chance to meet with the panelists.
Winterlight Labs announced a collaboration with Janssen Pharmaceuticals, facilitated by Johnson & Johnson Innovation, which will focus on developing a sensitive digital biomarker that can distinguish patients with mild cognitive impairment, an early stage of Alzheimer's Disease, from healthy elderly subjects.
Supported by the Ontario Centres of Excellence, the SmartStart Seed Fund supports youth (19-29) entrepreneurs involved in on-campus entrepreneurship activities. Applicants can receive up to $35,000 in seed funding and access to regional business and investment networks and resources.
AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has raised $3.25 million CAD in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners.